10 active not recruiting. 10 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Active not recruiting 10 |
| Phase 2 | 4 | Active not recruiting 4 |
Follow Gastroenteritis: new trials by email Literature Review of Gastroenteritis trials Research Report on Gastroenteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease Patients Vitamin D3 (Cholecalciferol) - Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease) | Phase 1 | Active not recruiting | Terry Ponich | 150 | 2025-11-05 | 2026-10-05 |
| A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease PALI-2108 - Fibrostenotic Crohn's Disease | Phase 1 | Active not recruiting | Palisade Bio | 6 | 2025-10-17 | 2026-02-23 |
| A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants GSK4528287, Placebo - Colitis, Ulcerative | Phase 1 | Active not recruiting | GlaxoSmithKline | 48 | 2024-11-18 | 2026-08-26 |
| CP101 for the Treatment of Ulcerative Colitis CP-101, CP-101 + Placebo - Ulcerative Colitis | Phase 1 | Active not recruiting | Brigham and Women's Hospital | 30 | 2023-09-01 | 2025-09-16 |
| Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis bacteriophage, Placebo - Shigellosis | Phase 1 / Phase 2 | Active not recruiting | Intralytix, Inc. | 52 | 2023-02-23 | 2025-06-15 |
| Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease EBFAHF-2, Placebo - Crohn's Disease | Phase 1 | Active not recruiting | Icahn School of Medicine at Mount Sinai | 7 | 2023-02-15 | 2025-09-23 |
| Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis Hydroxychloroquine, Mesalamine - Ulcerative Colitis (Disorder) | Phase 1 / Phase 2 | Active not recruiting | Icahn School of Medicine at Mount Sinai | 3 | 2022-06-10 | 2025-02-11 |
| Angiographic Delivery of AD-MSC for Ulcerative Colitis Adipose derived, autologous mesenchymal stem cells - Ulcerative Colitis | Phase 1 | Active not recruiting | Mayo Clinic | 20 | 2020-11-16 | 2026-01-21 |
| Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma Infliximab, Vedolizumab - Colitis, Lung Non-Small Cell Carcinoma | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 47 | 2020-07-09 | 2026-07-15 |
| Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease Placebo, Bacteriophage preparation - Crohn Disease | Phase 1 / Phase 2 | Active not recruiting | Intralytix, Inc. | 30 | 2019-05-01 | 2025-06-15 |
Colitis, Ulcerative (5) · Crohn Disease (5) · Inflammatory Bowel Diseases (4) · Carcinoma, Non-Small-Cell Lung (1) · Colitis (1) · Diabetes Mellitus, Insulin-Dependent, 12 (1) · Dysentery, Bacillary (1) · Melanoma (1) · Urogenital Neoplasms (1)
Digestive System Diseases (10) · Gastrointestinal Diseases (10) · Intestinal Diseases (10) · Colonic Diseases (6) · Colitis (5) · Inflammatory Bowel Diseases (4) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Dysentery (1) · Enterobacteriaceae Infections (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
CT-P13 (1) · Cholecalciferol (1) · Disulfides (1) · Hydroxychloroquine (1) · Immunoglobulin G (1) · Infliximab (1) · LDP-02 (1) · Mesalamine (1) · Saline Solution (1) · vedolizumab (1)
Icahn School of Medicine at Mount Sinai (2) · Intralytix, Inc. (2) · Brigham and Women's Hospital (1) · GlaxoSmithKline (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · Palisade Bio (1) · Terry Ponich (1)
United States (7) · Canada (2) · United Kingdom (1)
Alexander Sulakvelidze, PhD (1) · David Dunkin, MD (1) · Judy H Cho, MD (1) · Reezwana Chowdhury, MD (1) · Robert Hirten, MD (1) · Subra Kugathasan, MD (1) · Terry P Ponich, MD, FRCPC (1) · Wilbur Chen Chen, MD, MS (1) · William Faubion, MD (1) · Yinghong Wang (1)